Summary:
Assam is doing clinical trial of Covid-19 treatment with combination of two drugs, baricitinib and remdesivir which will reduce the recovery time among patients
.
Assam is doing clinical trial of Covid-19 treatment with combination of two drugs, baricitinib and remdesivir which will reduce the recovery time among patients.
While number of positive cases are starting to take more time than before to double but there is an increase in number of severe cases.
Himanta Biswa Sarma health minister said, “Currently, there are no approved therapies for the treatment of Covid-19, only clinical trials.
We are also having clinical trial of a combination baricitinib and remdesivir at Guwahati Medical College and Hospital, which is provides a reduction in time to recovery of hospitalized patients.”
Sarma said that over 1000 patients have so far received remdesivir and over 1880 have got plasma therapy.
“We have seen that plasma therapy is working when administered during the early stage,” he added.
“Number of cases in September so far is less than number of cases recorded in August.
But there is an increase in severity of cases.
If the current trend continues, we expect the death rate to reduce substantially by October.